t
On 5 February 2026, Unilever PLC issued and allotted 4,200,000 ordinary shares of 3 1/2p each to satisfy vesting awards under its employee share schemes. These shares were admitted to trading on the Main Market of the London Stock Exchange under an existing block admission dated 14 March 2024, increasing the total number of admitted ordinary shares to 2,185,205,247.
| Date | 5 Feb 2026 |
| Time | 16:06:56 |
| Category | Capital structure |
| ID | 9449R |
4,200,000 ordinary shares of 3 1/2p each in the Company (the "New Ordinary Shares") have been issued and allotted for the purposes of satisfying the vesting of awards under the Company's employee share schemes (the Unilever Share Plan 2017 (including the Unilever North America Omnibus Equity Compensation Plan) and the SHARES Plan) and admitted to trading on the Main Market of the LSE under the Company's existing block admission of shares for this purpose dated 14 March 2024.
The New Ordinary Shares will rank equally with the existing issued ordinary shares of the Company.
This notification is being made in accordance with UKLR 6.4.4 and PRM 1.6.2, and for PRM 1.6.2 purposes covers the period 15 September 2025 to 5 February 2026.
|
1 |
Details of the issuer |
|
|
a) |
Name |
Unilever PLC |
|
b) |
LEI |
549300MKFYEKVRWML317 |
|
2 |
Details of the transferable securities issued and admitted to trading |
|
|
a) |
Name, type and identification code |
Unilever PLC ordinary 3 1/2 pence shares GB00BVZK7T90 |
|
b) |
Regulated market |
London Stock Exchange - Main Market |
|
c) |
Number of further securities issued and admitted |
4,200,000 |
|
d) |
Total number of securities admitted following issuance |
2,185,205,247 ordinary shares
1,577,778 ordinary shares (not yet in issue) remain subject to the block admission dated 14 March 2024 |
|
e) |
Fungibility |
Fully fungible with existing ordinary shares |
|
3 |
Issue and admission details |
|
|
a) |
Dates of issuance and admission |
5 February 2026 (admitted under block admission dated 14 March 2024) |
|
b) |
Prospectus information |
Prospectus: N/A
Supplementary: N/A
Company's website: https://www.unilever.com/ |
For any enquiries, please contact:
Investor Relations: [email protected]
Unilever Press Office: [email protected]